US EditionPublished • loading... • Updated
FDA Reviews AI Mental Health Devices
Summary by DistilINFO Publications
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
FDA Reviews AI Mental Health Devices
FDA Advisory Committee Meeting Overview The Food and Drug Administration (FDA) is taking a significant step forward in evaluating artificial intelligence applications in healthcare by convening its Digital Health Advisory Committee on November 6, 2024. This crucial meeting will focus specifically on generative artificial intelligence-based digital mental health medical devices, marking a pivotal moment in the intersection of AI technology and me…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
